drugset / Trial / NCT03633175
Progesterone in Patients With Placenta Previa
RandomizedParallel-groupOpen-labelPrevention
Summary
This study evaluates the efficacy of prophylactic vaginal progesterone administration in reducing of the episodes of antepartum hemorrhage and subsequent prevention of preterm delivery in women with placenta previa.
Timeline
- Start
- 2018-07-05
- Primary completion
- 2019-07
- Completion
- 2019-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Progesterone | Other / unclassified | 400 mg | Other |